Quintiles Unveils the Next Generation of Quintiles Infosario

New Role-Based Navigation and Actionable Insights at a Study, Program, and Portfolio Level

RESEARCH TRIANGLE PARK, NC -- Quintiles today announced interactive, role-based navigation as part of the next generation of Quintiles Infosario® Reporting & Analytics Platform. Quintiles Infosario is an award-winning solution that seamlessly integrates data, systems, processes and Quintiles' therapeutic expertise to unlock faster, better-informed decisions from clinical trial planning and design, to trial execution services, through post-market outcome studies.

The new navigation introduces templates that allow users to create dashboards to view the most relevant data and visualizations for their specific, day-to-day needs. It also offers transparency into critical data at the study, program and portfolio levels—unlocking valuable insights that enable customers to tackle key challenges, such as real-time oversight, risk mitigation, patient safety, productivity and time to market.

With Quintiles Infosario:

Clinical program managers can view the overall status of trials in a specific region in near real-time, enabling quick and deliberate decisions to ensure trial success.
Pharmacovigilance scientists and medical monitors can easily focus on safety-specific data, enabling subtle but important signal detections for improved patient safety.
Site start-up specialists can seamlessly monitor patient enrollment at specific sites to forecast, benchmark and optimize the patient recruitment processes.
"Historically, our customers have experienced gaps in the availability of integrated, continuously updated data necessary to manage their studies," said Thomas Grundstrom, Vice President, Integrated Processes and Technologies. "With the next generation of Quintiles Infosario, users can easily view data according to their specific needs and make better-informed decisions to run more efficient clinical trials and accelerate time to market."

Quintiles Infosario® Reporting & Analytics Platform is built upon a patent-pending and system-independent data factory that easily integrates with customers' existing technology solutions to offer unique data points through advanced visualizations.

With Quintiles Infosario, Quintiles is delivering The Data Driven Difference™– the company's approach to harnessing the power of data from diverse sources in near real-time to help customers make the best possible decisions earlier in the product lifecycle.

For more information on Quintiles Infosario, visit Quintiles' website www.quintiles.com/infosario, or visit the Quintiles' booth for an in-person demonstration at the Society of Clinical Data Management annual conference, Sept. 22-25 in Los Angeles, Calif.

About Quintiles

Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. Our network of more than 25,000 professionals in 60 countries has an eye on the future while delivering results today with an unwavering commitment to patients, safety and ethics. Quintiles helps biopharmaceutical companies develop and commercialize products to improve and lengthen patients' lives while demonstrating value to stakeholders. Visit www.quintiles.com for more information and www.quintiles.com/news for additional company news.

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Decentralized study company Medable has raised a large $91 million funding round as it continues to ramp up the deals in 2020.

Biotech IPOs are up over 40% year-to-date, but today’s markets have rewritten the rules for going public. Find out the new best practices for IPOs.

PRA Health has hired a former FDA clinical research lead to help run its decentralized study unit.